In what is certainly a new high or a new low for this podcast, we explore how to calculate the “Kardashian Index” of your KOLs and scientific leaders.
Introducing the Foundations in Medical Affairs Certificate Program, an essential component of the MAPS eCademy Learning Journey, specifically designed to elevate your understanding of critical concepts and practices in Medical Affairs. With courses tailored to a wide range of fields, Ecademy fosters skill development and professional growth in a collaborative digital environment.
In this On-Demand webinar, you will discover how to view a demo on the use of GenAI in data fact validation, learn key lessons in implementing GenAI-based medical and regulatory checks, explore how to address potential gaps and identify opportunities to scale.
This S&G offers guidance, rationale for strategic evidence generation planning, as well as tips and tools to support with plan development, and practical guidance for investigator-initiated studies.
In this webinar, we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study.
In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.
Experts from Lumanity discuss cross-functional alignment of Integrated Evidence Generation Planning (IEGP) from perspectives of strategy, clinical/regulatory, commercial and patient engagement.
As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating RWE and HEOR alongside traditional approaches when planning data generation activities to support new product registration, access, and use.
Medical Affairs is in the unique position to drive health equity through three main roles: catalyser, capabilities enhancer, and cross-functional collaborator, emphasizing the need for deliberate strategies and actions to close health gaps and improve outcomes for underserved populations.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.